Table 2.
Post-treatment characteristics of the study patients for the overall cohort and by NLR.
| Variable |
n (%) (n = 168) |
NLR | ||
|---|---|---|---|---|
| Low (%) (n = 92) |
High (%) (n = 76) |
p Value | ||
| Type of Surgery | 0.519 | |||
| BCS | 99 (58.9) | 57 (62.0) | 42 (55.3) | |
| Mastectomy | 69 (41.1) | 35 (38.0) | 34 (44.7) | |
| pCR | 0.890 | |||
| Yes | 16 (9.50) | 9 (9.80) | 7 (9.20) | |
| No | 152 (90.5) | 83 (90.2) | 69 (90.8) | |
| Ki67 in Residual Tumor | 0.999 | |||
| <14% | 140 (83.4) | 77 (91.6) | 63 (92.6) | |
| ≥14% | 12 (7.10) | 7 (8.40) | 5 (7.40) | |
| Not determinable | 16 (9.50) | |||
| Size of Residual Tumor | ||||
| ≤2 cm | 111 (66.1) | 59 (64.1) | 52 (68.4) | 0.674 |
| >2 cm | 57 (33.9) | 33 (35.9) | 24 (31.6) | |
| No. of Metastatic Nodes | ||||
| ≤3 | 127 (75.6) | 74 (80.4) | 53 (69.7) | 0.154 |
| >3 | 41 (24.4) | 18 (19.6) | 23 (30.3) | |
| Stage | ||||
| 0–I | 47 (28.0) | 25 (27.2) | 22 (28.9) | 0.472 |
| II | 75 (44.6) | 46 (50.0) | 29 (38.2) | |
| III | 46 (27.4) | 21 (22.8) | 25 (32.9) | |
BCS, breast-conserving surgery; pCR, pathological complete response.